Page last updated: 2024-09-03

n,n-dimethylarginine and perindopril

n,n-dimethylarginine has been researched along with perindopril in 3 studies

Compound Research Comparison

Studies (n,n-dimethylarginine)	Trials (n,n-dimethylarginine)	Recent Studies (post-2010) (n,n-dimethylarginine)	Studies (perindopril)	Trials (perindopril)	Recent Studies (post-2010) (perindopril)
2,216	228	1,221	1,829	556	497

Protein Interaction Comparison

Protein	Taxonomy	n,n-dimethylarginine (IC50)	perindopril (IC50)
Angiotensin-converting enzyme	Homo sapiens (human)		0.0015

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A	1
Hirata, Y	1
Abo-Saif, AA; Mohamed, WR; Mohamed, YT; Naguib, IA	1

Reviews

1 review(s) available for n,n-dimethylarginine and perindopril

Article	Year
[NO and hypertension]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Arteriosclerosis; Biopterins; C-Reactive Protein; Endothelium, Vascular; Humans; Hypertension; Mutation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species; Vasodilation	2004

Article

Year

[NO and hypertension].

Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3

Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Arteriosclerosis; Biopterins; C-Reactive Protein; Endothelium, Vascular; Humans; Hypertension; Mutation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species; Vasodilation

2004

Other Studies

2 other study(ies) available for n,n-dimethylarginine and perindopril

Article	Year
Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus. Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:9 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunoassay; Male; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Perindopril; Renin-Angiotensin System; von Willebrand Factor	2002
Protective effects of perindopril against indomethacin-induced gastric mucosal damage through modulation of DDAH-1/ADMA and ACE-2/ANG-(1-7) signaling pathways. Drug and chemical toxicology, 2022, Volume: 45, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclooxygenase 2; Indomethacin; Pantoprazole; Perindopril; Prostaglandins E; Rats; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha	2022

Article

Year

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.

Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:9

Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunoassay; Male; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Perindopril; Renin-Angiotensin System; von Willebrand Factor

2002

Protective effects of perindopril against indomethacin-induced gastric mucosal damage through modulation of DDAH-1/ADMA and ACE-2/ANG-(1-7) signaling pathways.

Drug and chemical toxicology, 2022, Volume: 45, Issue:6

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclooxygenase 2; Indomethacin; Pantoprazole; Perindopril; Prostaglandins E; Rats; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2022